Medico Remedies Statistics
Total Valuation
Medico Remedies has a market cap or net worth of INR 4.66 billion. The enterprise value is 4.76 billion.
Market Cap | 4.66B |
Enterprise Value | 4.76B |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
Earnings Date | May 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +1.38% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 16.40M |
Valuation Ratios
The trailing PE ratio is 52.60.
PE Ratio | 52.60 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 8.40 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 53.72 |
EV / Sales | 3.15 |
EV / EBITDA | 36.63 |
EV / EBIT | 47.64 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.21 |
Debt / EBITDA | 0.88 |
Debt / FCF | n/a |
Interest Coverage | 13.66 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 10.18% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 7.82M |
Profits Per Employee | 458,627 |
Employee Count | 193 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.19% in the last 52 weeks. The beta is 0.23, so Medico Remedies's price volatility has been lower than the market average.
Beta (5Y) | 0.23 |
52-Week Price Change | -33.19% |
50-Day Moving Average | 65.32 |
200-Day Moving Average | 50.43 |
Relative Strength Index (RSI) | 40.25 |
Average Volume (20 Days) | 1,867,598 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medico Remedies had revenue of INR 1.51 billion and earned 88.52 million in profits. Earnings per share was 1.06.
Revenue | 1.51B |
Gross Profit | 382.70M |
Operating Income | 99.81M |
Pretax Income | 120.50M |
Net Income | 88.52M |
EBITDA | 125.64M |
EBIT | 99.81M |
Earnings Per Share (EPS) | 1.06 |
Balance Sheet
The company has 15.23 million in cash and 114.11 million in debt, giving a net cash position of -98.88 million.
Cash & Cash Equivalents | 15.23M |
Total Debt | 114.11M |
Net Cash | -98.88M |
Net Cash Per Share | n/a |
Equity (Book Value) | 555.08M |
Book Value Per Share | 6.79 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 25.35%, with operating and profit margins of 6.61% and 5.86%.
Gross Margin | 25.35% |
Operating Margin | 6.61% |
Pretax Margin | 7.98% |
Profit Margin | 5.86% |
EBITDA Margin | 8.32% |
EBIT Margin | 6.61% |
FCF Margin | n/a |
Dividends & Yields
Medico Remedies does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.38% |
Shareholder Yield | -1.38% |
Earnings Yield | 1.90% |
FCF Yield | n/a |
Stock Splits
The last stock split was on March 16, 2023. It was a forward split with a ratio of 5.
Last Split Date | Mar 16, 2023 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |